Regenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem Cells
Type 1 diabetes is an autoimmune disease resulting in the permanent destruction of pancreatic islets. Islet transplantation to portal vein provides an approach to compensate for loss of insulin producing cells. Clinical trials demonstrated that even partial islet graft function reduces severe hypogl...
Saved in:
Main Authors: | Nadine E. Rekittke, Meidjie Ang, Divya Rawat, Rahul Khatri, Thomas Linn |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2016/3764681 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oxygenation of the Intraportally Transplanted Pancreatic Islet
by: Thomas M. Suszynski, et al.
Published: (2016-01-01) -
Revascularization of Transplanted Pancreatic Islets and Role of the Transplantation Site
by: Andrew R. Pepper, et al.
Published: (2013-01-01) -
Evolution of 𝜷-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell Transplantation
by: Cyrus Jahansouz, et al.
Published: (2011-01-01) -
Mesenchymal Stem Cells and Regenerative Medicine
by: Huseyin Sumer, et al.
Published: (2018-01-01) -
The Fate of Allogeneic Pancreatic Islets following Intraportal Transplantation: Challenges and Solutions
by: Xinyu Li, et al.
Published: (2018-01-01)